dapsone has been researched along with cimetidine in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (37.14) | 18.2507 |
2000's | 10 (28.57) | 29.6817 |
2010's | 11 (31.43) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Coleman, MD; Park, BK; Russell, RM; Tingle, MD | 1 |
Breckenridge, AM; Coleman, MD; Friedmann, PS; Park, BK; Rhodes, LE; Scott, AK; Verbov, JL | 1 |
Coleman, MD; Park, BK; Tingle, MD | 3 |
Breckenridge, AM; Coleman, MD; Hoaksey, PE; Park, BK | 1 |
Breckenridge, AM; Coleman, MD; Park, BK; Scott, AK | 1 |
Breckenridge, AM; Coleman, MD; Park, BK; Winn, MJ | 1 |
Chu, P; Friedmann, PS; Park, BK; Rhodes, LE; Tingle, MD; Verbov, JL | 1 |
Ahmadi, M; Khalaf, LF; Nicholls, PJ; Smith, HJ | 1 |
Hiscott, P; Kaye, SB; Morton, CE; Needham, A; Scott, JA; Watson, A | 1 |
Bajpai, PK; Berty, S; Lasserre, A | 1 |
Cai, S; Castela-Papin, N; Farinotti, R; Keller, F; Souleau, CH; Vatier, J | 1 |
Bormann, G; Fischer, M; Gaber, G; Marsch, WC | 1 |
Dave, JK; Jha, SH; Reddy, JA | 1 |
Mehta, M | 1 |
Coleman, MD | 1 |
Goolamali, SI; Macfarlane, CS | 1 |
Kast, RE | 1 |
2 review(s) available for dapsone and cimetidine
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
33 other study(ies) available for dapsone and cimetidine
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Topics: Acetylation; Animals; Cimetidine; Dapsone; Drug Interactions; Half-Life; Male; Methemoglobin; Methemoglobinemia; Rats; Rats, Inbred Strains; Trimethoprim | 1992 |
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dapsone; Dermatitis Herpetiformis; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Methemoglobinemia; Middle Aged | 1992 |
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Topics: Animals; Chromatography, High Pressure Liquid; Cimetidine; Dapsone; Hydroxylation; Male; Methemoglobinemia; Rats; Rats, Inbred Strains | 1991 |
The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Topics: Adolescent; Adult; Animals; Child; Cimetidine; Dapsone; Humans; Hydroxylation; Male; Methemoglobin; Microsomes, Liver; Middle Aged; NADP; Rats | 1991 |
Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Topics: Animals; Bile; Chromatography, High Pressure Liquid; Cimetidine; Dapsone; Half-Life; Liver; Male; Methemoglobinemia; Oxygen Consumption; Perfusion; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet | 1990 |
The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Topics: Adult; Cimetidine; Dapsone; Humans; Hydroxylation; Male; Methemoglobinemia | 1990 |
An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Topics: Cimetidine; Dapsone; Enzyme Induction; Humans; Ketoconazole; Methemoglobin; Microsomes, Liver; NADP | 1990 |
Inhibition of dapsone-induced methaemoglobinaemia in the rat.
Topics: Animals; Cimetidine; Dapsone; Male; Methemoglobinemia; Piperonyl Butoxide; Rats; Rats, Inbred Strains | 1990 |
Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dapsone; Dermatitis Herpetiformis; Drug Therapy, Combination; Female; Headache; Hemolysis; Humans; Male; Methemoglobin; Middle Aged; Pain Measurement | 1995 |
A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
Topics: Animals; Cimetidine; Dapsone; Enzyme Inhibitors; Female; Folic Acid Antagonists; Histamine H2 Antagonists; Humans; Leukocytes, Mononuclear; Male; Methemoglobinemia; Mice; Microsomes, Liver | 1996 |
Superior tarsal conjunctival bullae in cicatricial pemphigoid.
Topics: Anti-Infective Agents; Anti-Ulcer Agents; Blister; Cimetidine; Conjunctival Diseases; Dapsone; Drug Therapy, Combination; Eyelids; Female; Humans; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane | 1997 |
In vitro and in vivo dapsone release from hydroxyapatite reservoirs.
Topics: Animals; Biocompatible Materials; Cimetidine; Dapsone; Drug Implants; Durapatite; Leprostatic Agents; Male; Rats; Rats, Sprague-Dawley | 1997 |
Drug interactions with diosmectite: a study using the artificial stomach-duodenum model.
Topics: Adsorption; Animals; Anti-Infective Agents; Cimetidine; Dapsone; Digoxin; Drug Interactions; Duodenum; Fluoroquinolones; Gastric Mucosa; Gastrointestinal Agents; Hydrogen-Ion Concentration; Intestinal Absorption; Metronidazole; Models, Biological; Pharmacokinetics; Silicates; Stomach; Swine; Valproic Acid | 1999 |
Dapsone in rosacea fulminans.
Topics: Administration, Oral; Biopsy, Needle; Cimetidine; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Facial Dermatoses; Female; Follow-Up Studies; Humans; Middle Aged; Rosacea; Severity of Illness Index; Treatment Outcome | 2001 |
Dapsone-induced acute pancreatitis.
Topics: Aged; Cimetidine; Dapsone; Dermatitis Herpetiformis; Humans; Male; Meperidine; Pancreatitis | 2003 |
Cimetidine and dapsone-mediated methaemoglobinaemia.
Topics: Anti-Infective Agents; Cimetidine; Dapsone; Histamine H2 Antagonists; Humans; Methemoglobinemia; Postoperative Complications | 2007 |
Improvement of patient tolerance to dapsone: current and future developments.
Topics: Antioxidants; Cimetidine; Dapsone; Dermatologic Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Thioctic Acid | 2007 |
The use of cimetidine to reduce dapsone-dependent haematological side-effects in a patient with mucous membrane pemphigoid.
Topics: Aged; Anemia, Hemolytic; Cimetidine; Dapsone; Humans; Immunosuppressive Agents; Male; Pemphigoid, Benign Mucous Membrane | 2009 |
Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation.
Topics: Cimetidine; Dapsone; Glioblastoma; Humans; Interleukin-8; Pemphigoid, Bullous; Pharmaceutical Preparations; Pilot Projects | 2021 |